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ABSTRACT 
Do Prospective Ratings Correct Retrospective Distortions 
Based on Negative Social Stereotypes 
of Premenstrual syndrome? 
by 
Mary L. stone, Master of Science 
Utah State University, 1994 
Major Professor: Dr. David M. Stein 
Department: Psychology 
The Daily Assessment Form (OAF) retrospectively 
assessed symptoms of late luteal phase dysphoric disorder 
(LLPDD), both at the beginning and at the end of a 2-month 
time interval. Ninety-four women between the ages of 18 and 
45 entered the study. Half of the subjects viewed a 
negative-case, stereotypic presentation of LLPDD prior to 
the pretest. sixty-eight subjects qualified on the pretest 
to complete the study. Half of the remaining no-case 
subjects and half of the remaining negative-case subjects 
completed 8 weeks' prospective ratings via the OAF. Forty-
eight subjects remained to complete the posttest at the end 
of that time interval. Pretest Total and Pretest Criteria 
scores revealed significant main effects for case-
presentation condition (E[l,63] = 7.08, R = .01) and 
(E[l,63] = 8.34, R = .01) and completion level (E[l,63] = 
6.76, R = .01) and (E[l,63] = 3.76, R .06). Effect sizes 
equalled 0.48 and 0.45 for case presentation and 1.92 and 
1.98 for completion. 
ix 
(85 pages) 
CHAPTER I 
INTRODUCTION 
The National Institute of Mental Health (NIMH} has 
stated that a useful definition of premenstrual syndrome 
(PMS) is a 
constellation of mood, behavior and/or physical 
symptoms which have a regular cyclical relationship to 
the luteal phase of the menstrual cycle, are present in 
most (if not all) cycles, and remit by the end of 
menstrual flow with a symptom-free interval of at least 
one week each cycle. (Workshop, 1983, quoted in 
Harrison , Rabkin, & Endicott, 1985, p. 789) 
More specific NIMH gu i de l ines for the diagnos i s of PMS 
include 
"the cyclic occurrence of (at least five] symptoms that 
are of sufficient severity to interfere with some 
aspects of life and which appear with consistent and 
predictable relationship to menses," with a) marked 
change of about 30% in the intensity of symptoms 
measured intermenstrually from days 5 to 10 as compared 
with that premenstrually (with 6 days before 
menstruation), and b) prospective documentation of 
these changes for at least two consecutive cycles. 
(Workshop, 1983, quoted in Gise, Lebovits, Paddison, & 
strain, 1990, p. 230) 
It is generally acknowledged that some women report 
experiencing symptoms of PMS, while others do not. However, 
what exactly are they reporting or failing to report? Most 
clinicians tend to rely on patients' retrospective reports 
(see the following paragraph) of symptoms in making a 
diagnosis. Retrospective reports are likely used for the 
sake of economy in order to provide symptom relief by 
offering a treatment as quickly as possible. However, 
patients' reports of the mere presence of symptoms commonly 
associated with PMS may be an insufficient basis for making 
a diagnosis of the syndrome. As noted by Rubinow, equally 
important are severity, timing, symptomatic baseline about 
which symptoms fluctuate, and method of establishing 
menstrual linkage of symptoms ("Diagnosis of PMS," 1987). 
Do women have a sufficiently accurate recall of their 
symptoms so that they can provide truly valid symptom 
reports? 
2 
Evidence pointing to women's apparent difficulty in 
adequately self-reporting their PMS symptoms is seen in the 
frequent discrepancies between retrospective versus 
prospective reports of premenstrual symptomatology (Cameron, 
Kuttesch, McPhee, & Curtis, 1988; Christensen, Oei, & 
Callan, 1989; Endicott & Halbreich, 1982; Endicott, Nee, 
Cohen, & Halbreich, 1986; Freeman, Sondheimer, & Rickels, 
1988; Freeman, Sondheimer, Weinbaum, & Rickels, 1985; Gise 
et al., 1990; Halbreich et al., 1989; Harrison, Endicott, 
Rabkin, & Nee, 1984; Kersey, Kruikov, Shannon, & Boyd, 1989; 
McMillan, Ghadirian, & Pihl, 1989; McMillan & Pihl, 1987; 
O'Boyle, Severino, & Hurt, 1988; Rapkin, Chang, & Reading, 
1988; Youdale & Freeman, 1987). Retrospective reports 
typically involve one or more of the subject's most recent 
cycles or her past premenstrual symptomatology. Prospective 
reports focus on current symptoms. They are usually 
completed daily. Thus, they are less reliant on subjects' 
long-term memory. Rubinow indicated that 50 to 70% of 
historical reports of PMS are not subsequently corroborated 
by prospective reports over 2 to 3 months ("Diagnosis of 
PMS , " 19 8 7 ) . 
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More specifically, prospective reporting involves a 
woman's daily recordings of her temperature (i.e., for 
determining ovulation), the presence or absence of 
menstruation, and the presence and severity of physical 
and/or emotional symptoms {Severino & Moline, 1989). Such 
information provides a symptomatic baseline about which 
symptom severity fluctuates, as well as an objective look at 
how changes in symptomatology do or do not correlate with 
hormonal changes. Such an objective view would serve either 
to substantiate or to disqualify women's prior 
conceptualizations of premenstrual symptomatology. It may 
also provide a "corrective learning experience" (Bandura, 
1977, p. 78) for those women whose prior (i.e., 
retrospective) notions of PMS were not in line with their 
more immediate objective view. 
A number of studies have documented differences between 
women's retrospective and prospective reports about PMS, but 
little parallel research has been conducted on the 
"official," American Psychiatric Association (APA) 
equivalent of PMS, which is called late luteal phase 
dysphoric disorder (LLPDD), as listed in the Diagnostic and 
Statistical Manual of Mental Disorders {Third Edition -
Revised) {DSM-III-R) {APA, 1987). Research studies dealing 
with retrospective versus prospective assessment of LLPDD 
are practically nonexistent. Such studies are needed to 
support or refute results obtained from previous studies, 
which typically lack well-conceptualized and/or widely-
agreed-upon definitions of PMS. 
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Severino and Moline {1989) described differences 
between PMS and LLPDD along three dimensions: (a) symptom 
presence, (b) timing, and (c) severity. First of all, at 
least one symptom of LLPDD must be of an emotional or 
affective nature (i . e ., affective lab i lity, anger or 
irritability, anxiety, and depression) {APA, 1987). Such is 
not necessarily the case with PMS. Second, symptoms of 
LLPDD must appear within 1 week prior to and remit within 2 
or 3 days following the onset of menses, whereas symptoms of 
PMS may begin at any time between ovulation and menses. 
Finally, symptoms of LLPDD are generally more debilitating 
than PMS, causing functional impairment in at least one 
major life area (i.e., work, usual social activities, 
relationships with others) (APA, 1987). A provisional 
diagnosis of LLPDD is based on a year's history during which 
symptoms are present in most cycles and confirmed, as is 
PMS, by 2 months' prospective daily ratings {APA, 1987; 
Severino & Moline, 1989). 
Also lacking in the literature are studies addressing 
the factors which may affect or influence subjects' recall 
of both past and current symptomatology, as reflected in 
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retrospective versus prospective ratings. As will be 
addressed in the literature review, one hypothesis 
accounting for the discrepancies found between retrospective 
and prospective reports of PMS or LLPDD is that women's 
retrospective recall is more prone than their prospective 
reports to be influenced by negative expectations or social 
stereotypes of PMS or LLPDD (Cameron et al., 1988; Endicott 
& Halbreich, 1982; Youdale & Freeman, 1987). That is, 
relative to their prospective ratings, women may base 
retrospect i ve reports primarily on recall of their own 
"worst" episodes and what they have been taught about 
negative social stereotypes regarding PMS or LLPDD. 
Examples of such stereotypes are provided by Paige 
(1973). One can infer from her article that intellectual 
unreliability, emotional instability, and a state of being 
unfit for strenuous physical exertion are three main 
categories of stereotypes typically employed in regard to 
PMS. 
Prospective evaluation may provide compelling, 
immediate information about PMS or LLPDD and correct women's 
tendency to make extreme and negative retrospective reports. 
The question of whether training/experience with prospective 
ratings may correct extreme beliefs and expectations about 
PMS or LLPDD (i.e., that it usually involves many diverse 
psychological symptoms at an extreme level of severity) has 
not been studied to date. 
CHAPTER II 
REVIEW OF THE LITERATURE 
Retrospective Versus Prospective 
Reports 
The review of the literature will address the question 
of whether retrospective or prospective reports provide the 
most valid representation of premenstrual-syndrome (PMS} or 
late-luteal-phase-dysphoric-disorder (LLPDD) symptoms. 
Hypotheses accounting for discrepant results found between 
measuremen t techniques will be presented along with 
pertinent literature addressing that topic. 
It has been suggested by some writers (Cameron et al., 
1988; Endicott & Halbreich, 1982; Youdale & Freeman, 1987) 
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that the validity of patients' reports of symptoms of PMS or 
LLPDD may be enhanced if patients were to monitor them daily 
rather than provide only retrospective reports. The 
question of the general validity of retrospective- versus 
prospective-assessment techniques in psychology and medicine 
has encompassed many domains. Those have included, for 
example, chronic pain (Linton & Gotestam, 1983; Linton & 
Melin, 1982), labor and postdelivery pain (Niven & Gushers, 
1984; Norvell, Gaston-Johansson, & Fridh, 1987; Rofe & 
Algom, 1985), alcohol consumption (Hilton, 1989), head 
trauma (Hunter, Philips, & Rachman, 1979), seizure frequency 
(Glueckauf, Girvin, Braun, & Bochen, 1990), nutritional 
status (Vobecky, Vobecky, & Freda, 1988), physical activity 
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(Wilbur, Miller, Dan, & Holm, 1989), and acute coronary pain 
(Pakula & Milvidaite, 1983). 
The recurrent, aversive, physical, and emotional 
qualities of PMS or LLPDD share more conceptual overlap with 
the chronic pain state than with any of the other domains 
cited above. Results from studies of retrospective versus 
prospective assessments of chronic pain do, in fact, 
parallel results obtained from retrospective versus 
prospective assessments of PMS conducted to date. 
Generally, the data show that, relative to prospective 
assessment, retrospective reports of chronic pain tend to 
involve an overestimation of severity of symptoms, whereas 
retrospective reports of PMS or LLPDD tend to involve 
greater numbers of symptoms, a possible overestimation of 
severity of symptoms, and inappropriate timing of symptoms. 
Speculations about Causes 
of the Rating Discrepancy 
A number of hypotheses have been offered in the PMS 
literature to account for discrepancies found between 
retrospective and prospective reports of the syndrome. 
Those discrepancies seem to be generally in the direction of 
retrospective overestimation of number and severity of 
symptoms. One hypothesis attributes discrepancies to faulty 
recall based on extreme, negative expectations or 
stereotypical beliefs involving more numerous and severe 
symptoms than are actually acknowledged prospectively 
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(Cameron et al., 1988; Endicott & Halbreich, 1982; Youdale & 
Freeman, 1987). 
Beliefs and Social Stereotypes 
about Extreme PMS/LLPDD 
Symptoms 
A number of authors have referred to the notion that 
menstrual beliefs influence experience of menstrual 
symptomatology (Caplan, Mccurdy-Myers, & Gans, 1992; Walsh, 
1987). Brooks - Gunn (1986) indicated that "we do not know to 
what extent" that is the case (p. 385). However, 
it has been hypothesized that premenstrual syndrome is 
[purely) the result of our expectations and attitudes 
toward menstruation, and that the reports of 
premenstrual symptoms are simply reflective of 
stereotypic beliefs concerning menstruation rather than 
of symptoms actually experienced. (Rolker-Dolinsky, 
1987, p. 116) 
Ainscough (1990) and Gallant and Hamilton (1992) have 
supported that view as accounting for discrepancies between 
retrospective and prospective reports. Ainscough attributed 
those discrepancies to a "widespread cultural belief that 
premenstrual negative affect is part of a woman's normal 
experience" (p. 43). Gallant and Hamilton referred to the 
retrospective diagnosis of LLPDD as being 
less compelling ... than other diagnoses based on 
retrospective reports [due to the role of) cultural 
stereotypes about the debilitating effects of 
menstruation on women's psychological and behavioral 
functioning, and the negative emotional characteristics 
attributed to being ''premenstrual." (pp. 726-727) 
Both the popular literature of the media and the 
medical literature of the health-care system have been cited 
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as vehicles for the promulgation of those stereotypes. 
Chrisler and Levy (1990) conducted a content analysis of 78 
magazine articles in press between 1980 and 1987 in order to 
evaluate their descriptions of premenstrual syndrome. The 
authors found 
a strong bias in favor of reporting negative menstrual 
cycle changes. Articles are generally negative in tone 
and present a confusing array of symptoms and 
contradictory treatment recommendations. The media 
coverage of PMS supports the stereotype of the 
maladjusted woman. (p. 89) 
Rittenhouse (1991), as well, placed much of the blame 
for propagating a negative premenstrual stereotype on the 
popular literature, "which problematizes both women and 
their cycles [and takes] for granted that the majority of 
women" suffer from PMS (pp. 416, 417). Jurgens and Powers 
(1991), however, implicated the health-care system as being 
"partly responsible for women's misconceptions and 
discomforts about their bodies" (p. 39). They indicated 
that 
medical literature reflects and reinforces negative 
images and promulgates false information regarding 
natural female processes, which have often been 
addressed within the idiom of "disease" and 
"dysfunction." (p. 39) 
A number of studies have lent credibility to the notion 
that menstrual beliefs influence symptom reports of PMS or 
LLPDD. A landmark study was conducted by Ruble {1977). She 
administered the Moos Menstrual Distress Questionnaire (MDQ) 
(Moos, 1968) , 
consisting of 48 items, 46 of which form eight clusters 
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of symptoms, [to] 48 women undergraduates at Princeton 
University, aged 18 to 24, who were not taking oral 
contraceptives at the time of the study nor had taken 
them within the previous 3 months. (p. 291} 
Ruble indicated that "variability in the length of their 
cycles did not exceed 2 weeks" (p. 291). 
"Women's perceptions of their cycle phase were 
separated experimentally from actual cycle phase" (Ruble, 
1977, p. 291). T tests were utilized to show that "women 
who were led to believe that they were premenstrual reported 
experiencing a significantly higher degree of several 
physical symptoms, such as water retention" (R < .01), pain 
(R < .05), change in eating habits (R < .025), and sexual 
arousal (R < .05} "than did women who were led to believe 
they were intermenstrual" (Ruble, 1977, p. 291). 
Means and standard deviations for the premenstrual 
group (n = 15) were as follows: M = 2.62, SD= 0.29 for 
water retention; M = 2.32, SD= 0.17 for pain; M = 2.93, SD 
= 0.51 for change in eating habits; and M = 3.60, SD= 0.42 
for sexual arousal. Means and standard deviations for the 
intermenstrual group (n = 14} were as follows: M = 1.54, SD 
= 0.12 for water retention; M = 1.88, SD= 0.17 for pain; M 
= 1.57, SD= 0.27 for change in eating habits; and M = 2.50, 
SD= 0.40 for sexual arousal. 
Another study, conducted by Parlee (1974), provided 
support for the existence of social stereotypes regarding 
PMS. She compared responses of men and women on the Moos 
Menstrual Distress Questionnaire (Moos, 1968}. Subjects 
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were asked to complete the inventory in line with their 
expectations of what women purportedly experience during the 
three phases of the menstrual cycle. Findings indicated 
that males, like females, anticipated greater symptom 
presence both premenstrually and menstrually than during the 
intermenstruum. Males and females both tended to rank order 
similar categories of symptoms they believed showed the 
greatest change in severity throughout the cycle (i.e., 
pain, water retention, and negative affect). However, males 
tended to report anticipating greater symptom severity 
overall than did their female counterparts. 
Parlee (1974) suggested that expectations regarding the 
menstrual cycle are "learned through a myriad of social 
sources" (p. 238) and that ''the beliefs seem to be more 
strongly held (more extreme) by those with little 
opportunity to acquire falsifying information" (p. 239). 
She seems to allude to the idea that women's own personal 
experiences with menstruation possibly temper views imposed 
by associations, communications, and social contacts. Men's 
views, on the other hand, remain untempered because of a 
lack of such experience. Therefore, their views fall more 
in line with society's extreme expectations. As mentioned 
previously, Paige (1973) listed emotional instability, 
intellectual unreliability, and a state of being unfit for 
strenuous physical exertion as examples of such negative 
stereotypes. 
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A similar study was conducted by Clarke and Ruble 
(1978) in which three groups of adolescents were assessed 
regarding their beliefs about menstruation. 
The subjects were 18 postmenarcheal girls (mean age 12-
11), 18 premenarcheal girls (mean age 12-5), and 18 
boys (mean age 12-10). All were in the sixth to eighth 
grades of four junior high schools in a white, middle-
to upper-class area. (p. 232) 
The Moos Menstrual Distress Questionnaire (1968) was again 
used as the dependent variable for assessing what subjects 
thought "'girls in general' experience during the menstrual 
phase and during the intermenstrual phase" of the cycle (p. 
23 2) . 
A 3 x 2 repeated measures ANOVA (group x phase) showed 
that all groups rated girls' experience of symptoms 
significantly (2 < .001) higher in the menstrual phase 
than in the intermenstrual phase, for all variables 
except Arousal, which was higher for the intermenstrual 
phase. (Clarke & Ruble, 1978, p. 232) 
The authors likely used an E test to determine level of 
statistical significance. "The largest phase differences 
were for Pain, Behavioral Change, and Negative Affect" (p. 
232). Such results obtained from an adolescent sample and 
paralleling those obtained from Farlee's (1974) adult sample 
indicate that menstrual attitudes develop early in our 
culture and are fairly uniform among males and females. 
Such would allude to a cultural or learning basis for such 
attitudes, beliefs, and expectations. 
In summary, substantial evidence in the literature 
supports the notion that culture-bound, stereotypic beliefs 
regarding PMS or LLPDD are highly influential in directing 
women's views of their own personal experiences of the 
disorder as well as society's more general views. Though 
women's personal experiences may diminish the effect of 
those stereotypes somewhat, it can be plainly seen that 
symptom reports, whether concurrent or historical, can be 
altered by the mere mention of the syndrome. Both men and 
women, boys and girls tend to view symptoms of PMS in a 
similar light, one which is extreme in its negativity. 
Memory Issues in Retrospective 
Reports 
As mentioned previously, faulty memory has been 
implicated as a causal factor of the noted discrepancy 
between retrospective and prospective reports. It may, 
indeed, play a crucial role in furthering the impact of 
stereotypical beliefs on subjects' ability to recall past 
symptomatology. A number of studies support the notion of 
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faulty memory and its impact on retrospective reports of PMS 
or LLPDD. 
For example, Cameron et al. (1988) evaluated 10 women 
both retrospectively and prospectively on 25 symptoms of 
panic, general anxiety disorder, and LLPDD. Mean age of 
subjects was 34.3 (SD= 7.1). Prospective ratings were made 
daily by patients for at least one menstrual cycle. 
Clinicians' ratings were also made on a weekly basis. 
Retrospective ratings were made by subjects following 
completion of both daily (i.e., subjects' ratings) and 
14 
weekly (i.e., clinicians' ratings) prospective ratings. 
Discrepancies were found between retrospective and 
prospective measures. Retrospective reports indicated 
greater symptom fluctuations across the menstrual cycle with 
higher severity pre-/perimenstrually than either method of 
prospective reports. The authors attributed discrepancies 
to faulty recall based on negative expectations as well as 
upon nonspecific autonomic arousal at the premenstruum. 
Cameron et al. (1988) indicated: 
It is possible that the symptoms only show minimal 
variation (as indicated by the prospective ratings), 
but that ... women have learned from sources other than 
their own subjective experience to expect more or more 
severe symptoms in the premenstruum; thus, in the 
retrospective ratings, which are temporarily more 
removed from the actual experience than are the 
prospective daily ratings, subjects recall their 
symptoms as more severe at that point in the menstrual 
cycle. In other words, there is little actual 
fluctuation in symptomatology, but only an exaggeration 
due to an error of memory based on inappropriate 
expectation. (p. 173) 
In another study, Youdale and Freeman (1987) 
administered both the 95-item retrospective and the shorter 
prospective Premenstrual Assessment Forms (PAFs) (Halbreich, 
Endicott, Schacht, & Nee, 1982) to two groups of women, 19 
self-defined severely premenstrually symptomatic and 26 
self-defined premenstrually asymptomatic. Mean age of the 
symptomatic group was 32.11 (SD= 4.9). Mean age of the 
asymptomatic group was 29.84 (SD= 5.68}. Depressive 
syndrome was evaluated retrospectively with one PAF report 
involving the subjects' last three premenstrual phases. 
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Subjects were evaluated prospectively with nine PAFs: one 
premenstrual administration, one menstrual administration, 
and one intermenstrual administration for each of 3 months. 
Data revealed that retrospective reports were more 
severe than prospective reports. The retrospective 
assessment demonstrated that 95% of self-defined symptomatic 
subjects qualified as having depressive syndrome and that 
58% of self-defined asymptomatic subjects qualified. 
Prospective-assessment data revealed that 74% of self-
def i ned symptomatic subjects qualified as having depressive 
syndrome and that 27% of self-defined asymptomatic subjects 
qualified. Other PAF subtypes were also lower prospectively 
than retrospectively. 
The authors offered a number of speculations to account 
for discrepancies between retrospective and prospective 
estimates of symptomatology. They indicated that 
"retrospective perception of premenstrual symptomatology is 
based on stereotypical beliefs about the menstrual cycle" 
(Youdale & Freeman, 1987, p. 422). The authors offered no 
explanation, however, to clarify exactly what they meant by 
that. Overestimation of symptoms by those women without 
severe symptomatology and the possibility that retrospective 
reports may be more indicative of overall depression as 
opposed to purely premenstrual symptomatology were also 
offered as possible explanations to account for the 
aforementioned results. 
One other important point mentioned by Youdale and 
Freeman (1987) was that 53% of symptomatic and 27% of 
asymptomatic subjects met criteria for clinical PAF 
categories based on their intermenstrual reports. The 
authors suggested that women might be using the PAF rating 
scale as a measure of symptom severity rather than as a 
measure of change from base rate. Such would necessitate 
extra care in instructing women as to how to use the PAF. 
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To date, only one study has systematically examined the 
effects of daily self-monitoring of PMS on subjects' overall 
experience and view of their premenstrual symptomatology. 
Endicott and Halbreich (1982) administered the PAF to 48 
women both prior to and following administration of a 
prospective measure which included 1121 items of particular 
interest in ongoing studies by the authors" (p. 110). 
Prospective ratings were made on a daily basis by each 
subject for at least one menstrual cycle. 
Discrepancies were found between ratings. The second 
PAF rating was lower than the first. For instance, the pre-
PAF mean on the PAF Summary Scale for Depressed Mood and 
Ideation was 26; the post-PAF mean was 23. Also, the number 
of subjects whose pre-PAF ratings met criteria for Major 
Depressive Syndrome was 41; the number of post-PAF subjects 
was 27. The prospective ratings were also lower than the 
first PAF rating. Criteria for determining PMS included 
average premenstrual daily ratings being two points higher 
17 
than average postmenstrual daily ratings as well as 
subjects' exhibiting no frequency of depressive changes 
throughout the cycle. Overall, there was only a 59% 
confirmation of retrospective ratings by prospective 
ratings. Thirteen of 15 "severe" diagnoses were confirmed 
as well as 6 of 14 "moderate," and 5 of 12 "mild." Three of 
seven women who had not complained of PMS were found to 
exhibit depressive changes of a syndromal type. High levels 
of confirmation were limited to those women reporting severe 
PMS. 
Endicott and Halbreich (1982) indicated women may 
initially describe a scenario of their "worst case" (p. 110) 
of PMS when providing a retrospective report of symptoms 
over a period of past months. They suggested that subjects 
typically have no baseline against which to compare symptoms 
over time and that such reports cannot take into account the 
severity or timing of fluctuations in symptoms. Therefore, 
a lack of ongoing, systematic attention to critical 
premenstrual variables would hinder a woman's ability to 
recall symptoms. Rating symptoms on a daily basis may have 
served to eliminate any effects of faulty memory on symptom 
reports and shed lasting illumination on subsequent 
retrospective reports. 
Possible ways to improve upon the aforementioned study 
encompass a number of considerations. First of all, having 
subjects rate premenstrual symptoms prospectively for at 
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least 2 months is a guideline for diagnosis of LLPDD 
provided in DSM-III-R (APA, 1987). Subjects in Endicott's 
and Halbreich's study may have provided ratings for as short 
a period as 1 month. Second, assessing subjects for the 
more rigorously defined symptoms of LLPDD in place of the 
more loosely conceptualized symptoms of PMS would provide 
greater consensus and more precise focus for operationally 
defining the disorder. Fina l ly, experimental induction of 
negative expectations or stereotypical beliefs through 
presentation of a negative-case study of PMS or LLPDD could 
be employed as a means for testing the validity of the 
aforementioned hypothesis that expectations and beliefs 
influence recall and reports of symptoms. 
Summary 
In summary, discrepancies have been noted between 
retrospective and prospective assessments of PMS or LLPDD. 
Inherent in the literature is the general belief that 
prospective assessments provide a much more valid evaluation 
of PMS or LLPDD symptoms. One hypothesis attributes 
retrospective- versus prospective-rating discrepancies to 
faulty recall based on negative expectations or 
stereotypical beliefs. Learning how to conduct a 
prospective documentation of symptoms is thought to possibly 
correct for retrospective-reporting errors. 
A study addressing the validity of that hypothesis 
could assess the extent to which learning to prospectively 
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assess PMS or LLPDD symptoms alters retrospective ratings 
over time. Also, the study could incorporate a procedure 
for reinforcing negative expectations or stereotypical 
beliefs about PMS or LLPDD among women with the disorder. 
The extent to which such a procedure affects retrospective 
ratings could be examined. Further, the degree to which the 
prospective-rating process alters those biased reports could 
be evaluated. 
Specifically, one or more negative-case stereotype(s) 
of LLPDD would be presented to half of a group of subjects 
attesting to symptoms of LLPDD just prior to their making 
retrospective reports of their own symptomatology. The 
other half of the subjects would be given no case example(s) 
before giving their retrospective ratings of LLPDD. In 
addition, prospective ratings would then be collected from 
representative samples of each of those two groups, while 
other subgroups would simply continue the retrospective-
rating process. Thus, the study would examine whether 
prospective ratings correct reinforced, negative-case 
stereotypes and retrospective ratings. 
Overview 
CHAPTER III 
METHODS 
The basic study design included three main factors: 
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(a) case-presentation condition, (b) rating condition, and 
(c) time (i.e., a repeated-measures' factor). Four 
interactions of interest were also considered possible: (a) 
case - presentation condition x rating condition, (b) case-
presentation condition x time, (c) rating condition x time, 
and (d) case-presentation condition x rating condition x 
time (see Figure 1). 
Retrospective assessments of late-luteal-phase-
dysphoric-disorder (LLPDD) symptoms were obtained for 
subjects both at the beginning and at the end of a 2-month 
time interval. Those assessments evaluated changes in 
retrospective reports of symptomatology across time. That 
was the within-subjects' factor. However, half of those 
subjects were presented with a negative-case, stereotypic 
definition of LLPDD by means of videotape, while the other 
half received no case definition. The case presentation 
preceded subjects' first retrospective ratings. Also, half 
of the subjects in the negative-case-definition group and 
half of those in the no-case-definition group were 
administered 8 weeks' prospective ratings of LLPDD, while 
the other members of both groups continued retrospective-
only ratings. Thus, two between-subjects' factors (i.e., 
Retrospective-Only-
Rating Condition 
Group# 1 No-Case-
Presentation, 
Retrospective-Only-
Rating (NoC/R) 
Condition 
Retrospective-Plus-
Prospective-Rating 
condition 
Group# 2 No-Case-
Presentation, 
Retrospective-Plus-
Prospective-Rating 
(NoC/R+P) Condition 
No-case- Time 1 Retrospective 
Rating 1 
Time 1 Retrospective 
Rating 1 Presentation 
condition 
Negative-
Case-
Presentation 
condition 
Two-Month Time Lapse 
Time 2 Retrospective 
Rating 2 
Group# 3 Negative-
Case-Presentation, 
Retrospective-Only-
Rating (NegC/R) 
Condition 
Time 1 Retrospective 
Rating 1 
Two-Month Time Lapse 
Time 2 Retrospective 
Rating 2 
Two Months' Prospective 
Ratings 
Time 2 Retrospective 
Rating 2 
Group# 4 Negative-
Case-Presentation, 
Retrospective-Plus-
Prospective-Rating 
(NegC/R+P) Condition 
Time 1 Retrospective 
Rating 1 
Two Months' Prospective 
Ratings 
Time 2 Retrospective 
Rating 2 
Figure 1. Basic study design. 
Note: 2 (no-case presentation versus 
negative-case presentation) x 2 
(retrospective-only ratings versus 
retrospective-plus-prospective ratings) x 2 
(retrospective-rating period 1 versus 
retrospective-rating period 2) design. 
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negative-case presentation versus no-case presentation and 
retrospective-only ratings versus retrospective-plus-
prospective ratings) were employed. 
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Another main factor (i.e., completion level) emerged 
during the course of the study. That made possible a number 
of other interactions: (a) case-presentation condition x 
completion level, (b) rating condition x completion level, 
and (c) case-presentation condition x rating condition x 
completion level. 
Subject Defin i tion 
Female subjects were recruited from several large 
undergraduate classes at Utah State University . Subjects 
between the ages of 18 and 45 were selected based on the 
fact that women only experience premenstrual syndrome {PMS) 
or LLPDD (Severino & Moline, 1989). Those subjects who had 
undergone oophorectomies involving the surgical removal of 
both ovaries were excluded from participation. Subjects 
should also have been free of oral-contraceptive use so as 
to eliminate the confounding effects of artificial hormones 
on the body's natural hormonal cycle. Pregnant women were 
also omitted from the study. Finally, subjects needed to 
have been menstruating regularly (i.e., they must have had 
at least one menstrual period during the 2 months prior to 
their participation in the study). such specific criteria 
ensured physiological homogeneity within the sample and a 
lack of extraneous influences. 
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Incentives 
Informed consent to complete the screening inventory 
was obtained from each subject before admission to the 
study. (See Appendix A.) Female students received extra 
credit in line with the agreements they had with their 
instructors regarding participation in research. Those 
subjects whose results on the screening inventory indicated 
that they possibly experienced LLPDD and whose subsequent 
pretest scores indicated that they likely attributed their 
symptoms to the disorder were asked to complete the study. 
Equal proportions of various incentives (i.e., more extra-
credit points and 10 dollars per subject who completed the 
study-provided by the Women & Gender Research Institute on 
Utah State University campus) were offered across groups. 
Instrumentation 
The Daily Assessment Form (DAF) (Rivera-Tovar & Frank, 
1990) was chosen for the proposed study because of its 
emphasis on symptoms of LLPDD as well as for its parsimony 
and versatility. (See Appendix B.) Also, a review of the 
literature uncovered no other instrument developed 
specifically for the assessment of LLPDD. It was, 
therefore, necessary to make use of the DAF. The only other 
alternative would have been to develop a similar inventory. 
The DAF evaluates the presence and intensity of LLPDD 
using 33 items of physical (e.g., "low energy, fatigue, feel 
unable to move") and emotional (e.g., "irritable, angry, 
impatient") symptomatology, some of which are associated 
with specific LLPDD criteria and some of which are not. 
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Some of the items are considered to be "positive" (e.g., 
"feel excited, bursts of energy"), whereas most of the items 
are considered to be "negative'' (e.g., "irritable, angry, 
impatient"). None of the "positive" items are associated 
with any of the LLPDD criteria. Items are rated on a six-
point, Likert-type, severity scale. Scores range from 1, 
indicating the total absence of a given symptom, to 6, 
indicating the symptom to be extremely apparent or 
noticeable. 
One or more item(s) from the OAF is/are associated with 
each of the 10 LLPDD criteria listed in DSM-III-R (APA, 
1987). For cases involving more than one item per 
criterion, the mean of those items involved is calculated to 
produce a criterion score. APA (1987) guidelines for 
diagnosing LLPDD indicate that a subject must experience 
symptoms falling within at least five criteria. One of 
those criteria must be affective. Endicott and Halbreich 
(1982) also noted that only those retrospective reports made 
by subjects initially complaining of severe-intensity PMS 
were later substantiated by subjects' prospective reports. 
Therefore, a minimum of five criterion scores, one of them 
being affective, must be of moderate to extreme intensity 
for subjects to be considered as possible candidates for 
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study inclusion. It was thought that using a moderate score 
as the cut-off point for study inclusion would help to avoid 
exclusion of false negatives, though more false positives 
may have entered the initial phase of the study. Such were 
likely screened out later. 
As mentioned above, the inventory includes both 
symptoms which are and symptoms which are not relevant to 
making a diagnosis of LLPDD. The irrelevant symptoms helped 
to disguise the true focus of the inventory. Thus, subjects 
likely experiencing symptoms of the disorder could be 
identified without specifically educating them about all of 
the essential features of LLPDD. That aspect of the study 
was important as the investigator wanted to avoid 
contaminating initial ratings of symptoms or giving subjects 
cues about what specific symptoms were of interest to the 
investigator at that point in the study. 
A personal phone conversation with Heide Reppert, 
secretary to DAF coauthor, Ellen Frank, Ph.D. (November 26, 
1991), revealed a likely change in wording of future 
versions of the DAF. Rather than having subjects rate their 
degree of "change" of symptoms from 1 day to the next, the 
authors were simply going to require subjects to report 
their current severity of symptoms for each day. The 
present study made the anticipated correction so as to 
eliminate any confusion caused by the previous wording. 
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Prospective Use of the DAF 
Rivera-Tovar and Frank (1990) provided a description of 
their use of the DAF as it pertains to the prospective 
assessment of LLPDD. They indicated: 
The diagnosis of late luteal phase dysphoric disorder 
was determined by applying a rigorous percent-change 
criterion. Scores on the items on the Daily Assessment 
Form that corresponded to each of the 10 symptoms of 
the DSM-III-R criteria were summed and averaged over 
the 7 days before menses (premenstrual week) and the 7 
days after the cessation of menses (postmenstrual 
week) . For each symptom , the difference between the 
premenstrual average and the postmenstrual average 
(premenstrual minus postmenstrual) was divided by the 
postmenstrual average and expressed as percent change. 
A subject met the criteria for a given cycle if the 
averages for at least five of the 10 symptom areas 
showed a 30% or greater premenstrual increase in 
severity and if all postmenstrual averages were less 
than 3. In an attempt to exclude cases of chronic 
symptoms that were heightened premenstrually 
(premenstrual magnification), symptoms with a 
postmenstrual average score higher than or equal to 3 
(signifying "mild'' distress) were excluded. A positive 
diagnosis also required that at least one of the five 
symptoms be one of the first four symptoms listed in 
the DSM-III-R criteria (mood lability, irritability, 
anxiety, or depressed mood) and that the subject meet 
the criteria during at least two menstrual cycles. (p. 
1635) 
The prospective use of the DAF allows the researcher to 
make a differential diagnostic determination as to whether 
symptoms are truly confined to the late-luteal phase or 
whether they are more prevalent throughout the cycle, with 
or without a premenstrual exacerbation of symptoms. 
Criteria for making such a determination are included in the 
above instructions by Rivera-Tovar and Frank (1990). 
Because the present study was limited to an a-week, 
prospective-rating period, the author was able to collect 
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pre- and postmenstrual ratings for only one cycle for some 
of the subjects. Therefore, premenstrual days were averaged 
together, and postmenstrual days were averaged together for 
each cycle to determine that cycle's percent-change scores. 
Also, all premenstrual days were averaged together, and all 
postmenstrual days were averaged together in determining 
overall percent-change scores. So, it was possible to 
determine if a subject had met prospective-rating criteria 
based on each cycle's ratings as well as combined ratings. 
Retrospective Use of the DAF 
Retrospective-symptom reports by subjects on the DAF 
differed from the above application in that subjects were 
required to recall and report the premenstrual average 
intensity of symptoms of LLPDD from the prior 2 months' 
cycles. Again, a moderate score was used as the cut-off 
point for determining if a subject had experienced 
sufficient intensity of at least five symptoms, one of them 
being affective, corresponding to DSM-III-R criteria for 
LLPDD (APA, 1987; Endicott & Halbreich, 1982). 
A retrospective symptom-report format was also employed 
in the initial screening of subjects. The inventory was 
presented simply as a list of "physical and emotional 
symptoms" experienced by women "within the past 2 months" 
(see Appendix A) versus questioning them about their past 
two premenstrual or late-luteal phases, as in the above 
application. Thus, the researcher was able to collect 
pertinent screening data while avoiding subjects' self-
selection based on their preconceived notions of PMS. 
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Scoring for the retrospective application of the OAF 
was done in two ways. The first, the Total scoring method, 
incorporated all symptoms on the inventory. Severities of 
all symptoms considered to be "negative" were totalled at 
face value. Severity scores for all symptoms considered to 
be "positive" (i.e., "feel excited, bursts of energy," "feel 
more efficient, increased orderliness," and "sense of well-
being, more enjoyment of things") were reverse scored prior 
to their being added into the Total score. That was done 
for the purpose of gauging just how negatively a subject 
might have perceived and reported her past symptomatology. 
In developing the computer-scoring program, the author 
of the present study took into account the possibility that 
not all subjects would complete all 33 items on the 
inventory. Therefore, a mean score, the Total score divided 
by the total number of items completed, served as the true 
Total score for retrospective assessments on the OAF. 
The second method of retrospective scoring resulted in 
a Criteria score which incorporated only those symptoms 
specifically related to LLPDD criteria (see Table 1). As 
mentioned previously, in cases where more than one symptom 
corresponded to a given criterion, a mean score was 
obtained for those symptoms so that 10 criteria scores, some 
of them being means, were sumi~ed to total a grand Criteria 
Table 1 
Criterion/Symptom Correspondence 
Criterion 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
Symptom(s) 
4 
1 
5 
(10+11+17)/3 
(28+31)/2 
2 
16 
12 or 21 
19 or 29 
(7+8+15+22+26)/5 
Note. Information constituting this table was provided by 
the authors of the OAF. 
score. Once again, the author employed a mean Criteria 
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score, taking into account those instances in which not all 
items corresponding to LLPOO criteria were completed. 
Reliability and Validity 
of the OAF 
Reliability and validity data regarding the OAF were 
provided by Dr. Rivera-Tovar by telephone on May 19, 1992 
and again through the mail on May 22, 1992. Four subscales 
(i.e., negative affect, physical symptoms, agitation, and 
arousal) emerged as a result of factor analyzing items on 
the DAF. Internal consistency of those subscales ranged 
from what was considered to be an adequate score of .67 to a 
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high score of .96. Test-retest reliability or stability 
scores of the subscales were statistically significant. 
They ranged from .44 to .66. Dr. Rivera-Tovar indicated 
that intercyle variability of symptoms may have lowered the 
values somewhat. Dr. Rivera-Tovar considered prevalence 
rates of LLPDD when administering the OAF to a normative 
(i.e., 4.6%) versus a clinical (i.e., 62%) sample to be 
indicative of the validity of the instrument. 
Case Presentation of Negative 
PMS/LLPDD Stereotypes 
Specifically, the case presentation consisted of an 
interview situation in which a "subject" {i.e., a 
confederate of the interviewer) was retrospectively assessed 
for LLPDD using the OAF. The "subject" responded to all 
symptoms that could be perceived in a "negative" light 
(e.g., ''irritable, angry, impatient") at a severe-to-extreme 
intensity level. In addition, she avowed all symptoms that 
could be perceived in a "positive" light (e.g., "feel 
excited, bursts of energy'') at a negligible level of 
severity. Thus, the negative definition showcased a rather 
dysfunctional, severe example of LLPDD, leading subjects to 
infer that it was typical of most patients. As mentioned in 
the overview, the video clip was presented to half of the 
subjects in each of the rating groups just prior to their 
completing the pretest. 
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Procedures 
As mentioned previously, the screening inventory 
consisted of the DAF presented simply as a list of "physical 
and emotional symptoms" experienced by subjects "within the 
past 2 months." (See Appendix A.) Each of the study groups 
(see Figure 1) consisted of subjects whose scores on the 
screening inventory indicated they were experiencing LLPDD. 
Also, as noted, sufficient numbers of symptoms (i.e., at 
least five, one of them being affective) and intensity of 
symptoms (i . e ., moderate to extreme) corresponding to DSM-
III-R criteria were necessary to qualify subjects as 
evidencing LLPDD (APA, 1987; Endicott & Halbreich, 1982). 
Again, higher intensity of premenstrual complaints of 
subjects is a necessary criterion for study inclusion, 
Endicott and Halbreich having discovered a lack of 
confirmation of symptoms by those subjects complaining of 
lower intensity PMS. 
It was difficult to anticipate exactly how many 
individuals needed to be screened to fill each cell with 20 
to 30 subjects. However, the greater demands placed on 
subjects by the prospective ratings necessitated greater 
numbers of subjects being assigned to the prospective-rating 
condition. Approximately 500 women were screened in all. 
It was planned that at least 12 subjects would be retained 
within each cell by the end of the study. That number was 
thought to lend adequate statistical power to the data. 
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Subjects were informed by telephone that their scores 
on the screening inventory qualified them for further study 
participation and that they might be offered an additional 
incentive (i.e., possibly more extra-credit points and a 
possible monetary incentive) for continuing the study. The 
experimenter scheduled to meet with subjects individually 
for the purpose of briefing them as to what their study 
participation would involve. 
The pretest was administered to all subjects. Subjects 
who had met screening-inventory criteria had been randomly 
assigned to one of four treatment groups. (See Figure 1.) 
All groups were required to complete the DAF as it related 
to their two most recent premenstrual or late-luteal phases. 
Half of the subjects were presented with the video clip just 
prior to their taking the first retrospective DAF. Subjects 
in the no-case-presentation conditions simply completed 
their symptom ratings. A 2-month interval then lapsed 
before subjects were again required to complete the 
inventory retrospectively. Subjects in the retrospective-
plus-prospective-rating conditions, whether having viewed 
the video tape or not, completed both retrospective 
administrations of the DAF as well as 8 weeks' prospective 
ratings in between. 
The dependent variable for determining whether a 
subject would be retained for further study inclusion was 
the total number of DAF criterion scores, one of them being 
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affective, of moderate to extreme intensity (APA, 1987; 
Endicott & Halbreich, 1982). A proportion of the subjects 
who had passed the screening-inventory criteria were 
expected to attribute their symptomatology to something 
other than LLPDD. They would, therefore, have reported 
fewer, lower intensity symptoms on the first retrospective 
assessment of LLPDD and been dropped from study 
participation at that point (i.e., pretest disqualifiers). 
However, data were retained for all subjects who completed 
the pretest so that the effect of the video clip on symptom 
attributions could be ascertained. That was done to reveal 
the validity of the hypothesis that symptom reports of PMS 
or LLPDD are influenced by negative social stereotypes. 
It was also anticipated that the dropout rate for the 
retrospective-plus-prospective-rating groups would be more 
severe than for the retrospective-only-rating groups because 
of the time demands placed on the former subjects. 
Therefore, additional subjects were assigned to that more 
demanding rating condition. It was the concern that, due to 
the likelihood of higher drop-out rates, the retrospective-
plus-prospective-rating groups would become a more select 
sample of subjects than the retrospective-only-rating 
groups, the former demonstrating a greater degree of overall 
compliance and motivation than the latter. Pretest 
comparisons were later made to determine initial differences 
between those subjects who failed to complete their 
prospective ratings and were, therefore, not administered 
the posttest (i.e., posttest dropouts) and those subjects 
who subsequently completed the study. 
Data Analysis 
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Verification of the reliability of the DAF was sought 
by means of calculating Cronbach's alpha coefficients for 
determining internal consistency. Correlation coefficients 
were also calculated for verification of stability or test-
retest reliability of the instrument by means of comparing 
pre- and posttest scores of the control group. 
A number of methods were used to analyze demographic 
data from the sample. Age data were considered by employing 
separate two-by-two analyses of variance {ANOVAs) to 
determine significant differences between subjects in the 
case-presentation (i.e., no-case versus negative-case) and 
rating groups (i.e., retrospective-only versus 
retrospective-plus-prospective). Also, a one-way ANOVA was 
utilized to determine differences in age between those 
subjects meeting different levels of study completion (i.e., 
pretest disqualification versus posttest dropout versus full 
study). 
Other demographic characteristics of the sample (i.e., 
marital status, children, religion, and racial background) 
were examined. A frequency count was used to reveal the 
percentage of subjects falling within each category of a 
given characteristic. Contingency tables revealed 
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differences between subjects in the case-presentation (i.e., 
no-case versus negative-case) and rating conditions (i.e., 
pretest-disqualification, retrospective-only, and 
retrospective-plus-prospective) with regard to each of those 
variables. 
Analyses of variance were also employed in reference to 
screening data. Separate two-by-three ANOVAs for case 
presentation (i.e., no case and negative case) and rating 
(i.e., pretest disqualification , retrospective only, and 
retrospective p l us prospective) determined initial 
comparability of groups. One-way ANOVAs were also utilized 
to determine screening-score differences between subjects 
meeting different levels of study completion (i.e., pretest 
disqualification, posttest dropout, and full study) and 
between subjects having taken the inventory during different 
academic quarters. 
A 2-by-2-by-2 analysis of covariance (ANCOVA) for case 
presentation, rating, and completion was to be employed in 
analyzing pretest data. However, due to an empty cell, two 
2-by-2 comparisons were made instead. The first of those 
involved case presentation (i.e., no case and negative case) 
and rating (i.e., retrospective only and retrospective plus 
prospective). The second comparison involved case 
presentation (i.e., no case and negative case) and level of 
completion (i.e., posttest qropout and full study). 
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Finally, a multivariate-analysis-of-variance (MANOVA) 
approach to a repeated-measures test was employed. That was 
used to determine posttest differences between case 
presentation (i.e., no case and negative case) and rating 
(i.e., retrospective only and retrospective plus 
prospective) as well as to determine differences between 
pretest and posttest scores according to case-presentation 
and rating assignments and the passage of time. 
CHAPTER IV 
RESULTS 
Confirmation of DAF Reliability 
37 
The present study sought to verify internal consistency 
of the Daily Assessment Form (DAF) (Rivera-Tovar & Frank, 
1990). Therefore, Cronbach's alpha coefficients were 
calculated. An alpha coefficient of .92 was found for the 
pretest when c onsidering all 33 items on the inventory. A 
coefficient of .90 for the pretest was found when only those 
items specifically associated with LLPDD criteria were 
considered . Stability or test-retest reliability was also 
assessed by comparing the first and second retrospective 
ratings for the NoC/R group. Those ratings were 
administered approximately 2 months apart. A correlation 
coefficient of .59 was discovered for Pretest/Posttest Total 
scores and .62 for Pretest/Posttest Criteria scores. 
Sample Characteristics 
The 94 subjects participating in the study had a mean 
age of 22.05 (SD= 5.84). Two-by-two analyses of variance 
{ANOVAs) showed that no significant age differences were 
evident between subjects assigned to different case-
presentation (E[l, 64] = 0.00, p > .98) or rating groups 
(E[l, 64] = 1.53, p > .22). Also, no interaction was 
present (E[l,64] = 0.13, p > .72). Neither did a one-way 
ANOVA reveal a significant difference in age between those 
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subjects who (a) failed to meet criteria for study 
inclusion, (b) subsequently dropped out of the study, or (c) 
completed the full study (K[2, 91] = 0.71, ~ > .49). 
As has been mentioned in the Methods section, an 
attempt was made to solicit the participation of older 
subjects so that the age range was more representative of 
adult women generally. That was accomplished by including 
women involved in academic programs during summer quarter as 
well as those involved in more advanced undergraduate 
courses. However , the mean age of participants overall 
tended to fall near the lower end of the age continuum of 
adult women. A likely bias was the inclusion of large 
numbers of freshmen enrolled in the larger classes. 
A number of other sample characteristics (i.e., marital 
status, children, religion, and racial background) were 
examined. A frequency count revealed the vast majority of 
subjects to be single (i.e., 75.5%), white (i.e., 93.6%), 
Latter-Day-Saint (LDS) (i.e., 90.4%) females with no 
children (i.e., 85.1%). The majority of subjects deviating 
from that pattern were those who had had opportunities for 
marriage (i.e., 22.3% married at the time of the study, 2.1% 
divorced) and child rearing (i.e., 14.9%). Deviations in 
religion (i.e., 9.6% non-LDS) and racial background (i.e., 
3.2% Hispanic, 3.2% Asian) were infrequent. 
Pearson chi-square tests revealed no significant 
differences between case-presentation or rating groups with 
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respect to any of those demographic variables (i.e., for 
case-by-marital status x2 (2) = 1.46, R > .48; for rating 
group-by-marital status x2 (4)= 1.35, R > .85; for case-by-
children x2 (1) = 0.12, R > .72; for rating group-by-children 
x2 (2) = 0.88, R > .64; for case-by-religion, x2 (1) = 0.62, 
R > .43; for rating group-by-religion x2 (2) 4.08, R > .13; 
for case-by-racial background x2 (2) = 6.09, R > .04; and for 
rating group-by-racial background x2 (4) = 4.27, R > .37). 
Screening-Data Analyses 
Separate two-by-three ANOVAs involved a case-
presentation condition (i.e., no case versus negative case) 
and a rating condition (i.e., pretest disqualification 
versus retrospective only versus retrospective plus 
prospective). The Screening Total score and the Screening 
Criteria score were dependent variables. Those analyses 
were conducted to assess initial comparability of groups 
with regard to screening-inventory scores . It should be 
noted that the Screening Total score incorporated all 
questions on the screening inventory. The Screening 
Criteria score incorporated only those questions 
specifically related to the 10 late-luteal-phase-dysphoric-
disorder (LLPDD) criteria listed in DSM-III-R (APA, 1987). 
The means and standard deviations for the pretest-
disqualification-, retrospective-only-, and retrospective-
plus-prospective-rating groups are presented in Table 2. 
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Table 2 
Rating-Group Scores on Screening Inventories 
Screening Inventory 
Rating Group n Total Criteria 
Pretest disqual. 26 
M 3.32 3.73 
SQ 0.42 0.39 
Retrospective only 25 
M 3.79 4.13 
SD 0.48 0.57 
Retrospective plus 
prospective 43 
M 3.58 3.85 
SD 0.46 0.49 
Note. Higher scores indicate higher symptomatology. 
Boldface scores differ significantly from the others. 
The somewhat larger sample size for the retrospective-plus-
prospective-rating group reflects a priori planning for a 
possibly higher rate of subsequent dropouts for that group 
over the course of the study, as that group was subjected to 
greater task demands. Significant differences were noted 
between subjects initially assigned to rating groups on both 
the Screening Total score (E[2, 88] = 6.97, p ~ .002) and 
the Screening Criteria score (E[2, 88] = 4.74, p ~ .011). 
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Group contrasts on the screening Total revealed that 
the pretest-disqualificatiom-rating group (M = 3.32, SD= 
0.42) scored significantly lower than the means of 3.79 (SD 
= 0.48) and 3.58 (SD= 0.46 ~ for retrospective-only- and 
retrospective-plus-prospectftve-rating groups, respectively. 
Mean scores for the latter ~~o groups did not differ 
significantly. Those resul~s were expected, as subjects in 
the pretest-disqualification group later disqualified 
themselves from further participation because of their low, 
subsequent pretest scores. Because of their low degree of 
symptomatology, subjects in that rating group were not 
assigned to any research condition. 
Findings for the mean Screening Criteria breakdowns, 
however, were unexpected. Despite attempts to assign 
qualified subjects to experimental conditions on a strict 
rotating basis, the mean of 4.13 (SD= 0.57) for the 
retrospective-only-rating group was significantly higher 
than the mean of 3.85 (SD= 0.49) for the retrospective-
plus-prospective-rating group. Such a difference between 
mean scores for those rating groups suggested the need to 
statistically control for initial Screening Criteria 
differences in subsequent analyses. 
There was one other expected finding on the screening 
inventory. Screening Total differences discovered through a 
one-way ANOVA for those subjects meeting different levels or 
degrees of completion, as described in the following 
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paragraph, were significant (E[2, 91) = 4.90, p < .01). 
Scheffe posthoc tests revealed that the Screening Total 
score for the pretest-disqualification group (M = 3.32, SD 
0.42) was significantly lower than that for the posttest-
dropout group (M = 3.66, SD= 0.55) or that for the full-
study group (M = 3.66, SD= 0.45). (See Table 3.) That 
trend did not persist with the Screening Criteria scores 
(E[2, 91) = 1.81, 12 < .17). 
Table 3 
Completion-Group Scores on the Screening Total 
Completion Group n Screening Total 
Pretest 
disqualification 26 
M 3.32 
SD 0.42 
Posttest 
dropout 20 
M 3.66 
SD 0.55 
Full study 48 
M 3.66 
SD 0.45 
Note. Higher scores indicate higher symptomatology. 
Boldface scores differ significantly from the others. 
What these scores indicate is that those subjects who 
disqualify themselves (i.e., pretest-disqualification group) 
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by failing to meet LLPDD criteria report less numerous and 
severe symptoms on their screening inventories. Thus, there 
were some initial differences on the screening inventory 
between disqualifiers and those subjects whose subsequent 
pretest scores qualified them for further study 
participation. Pretest scores for the posttest-dropout and 
full-study groups qualified those subjects for further 
inclusion in the study. However, subjects in the posttest-
dropout group failed to meet study requirements (i . e., they 
primarily failed to complete their prospective ratings) . 
They were, therefore, dropped from the study prior to 
administration of the posttest . 
On the other hand, no other significant differences 
with regard to screening-inventory scores were found. For 
example, the two-by-three ANOVA revealed no significant mean 
differences due to case-presentation-group assignment on 
either the Screening Total score (E[l, 88] = 0.96, R > .32) 
or the Screening Criteria score (E[l, 88] = 2.39, R > .12). 
Neither did a one-way ANOVA reveal a significant difference 
in mean scores for subjects who had taken the screening 
inventory during different academic quarters on either the 
Screening Total score (E[2, 91] = 1.68, R > .19) or the 
Screening Criteria score (E[2, 91] = 0.44, R > .64). No 
interaction effect was present between case presentation and 
rating on either Screening Total scores (E[2,88] = 0.26, R > 
.77) or Screening Criteria scores (E[2,88] = 0.61, R > .54). 
In summary, with the exception of an apparent lack of 
comparability of the pretest-disqualification group, there 
appears to have been a fairly homogenous assignment of 
subjects into different treatment cells. Also, these data 
suggested the need to statistically control for Screening 
Criteria differences in analyses of pretest data. 
Analyses Involving Pretest Data 
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Because of screen i ng - score differences among study 
groups , the present author chose to report adjusted-mean 
pretest values: Pr etest scores were regressed onto the 
combination of Screening Criteria scores, case-presentation 
group assignment, rating-group assignment, and the group-
assignment indices. The predicted or adjusted-mean pretest 
score for each subject was then computed from the overall 
regression model. Subgroup means and standard deviations 
were calculated based on the resulting predicted Pretest 
Total and Pretest Criteria scores. Those means were then 
used in some of the calculations that follow. 
Pretest scores were analyzed by means of a 2-by-2-by-2 
analysis of covariance (ANCOVA) controlling for Screening 
Criteria scores. Interactions and main effects were 
examined for case-presentation group (coded no case and 
negative case), rating group (coded retrospective only and 
retrospective plus prospective), and completion level (coded 
posttest dropout and full study). It was discovered that no 
three-way interaction could be examined because of an empty 
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cell (i.e., no-case-presentation group, retrospective-only-
rating group, plus posttest-dropout-completion level). 
It was, therefore, necessary to analyze the pretest 
data by means of two separate two-by-two ANCOVAs. The first 
involved case presentation (i.e., no case versus negative 
case) and rating (i.e., retrospective only versus 
retrospective plus prospective) using the Pretest Total 
score, incorporating all questions on the pretest inventory, 
and the Pretest Criteria score, incorporating only those 
questions specifically related to the 10 late-luteal-phase-
dysphoric-disorder (LLPDD) criteria. 
A main effect was noted for the case-presentation 
condition on both the Pretest Total score (E[l, 63] = 5.67, 
2 ~ .020) and the Pretest Criteria score (E[l, 63] = 7.19, 2 
< .01). Effect sizes of 0.42 and 0.42 were found for 
Pretest Total and Pretest Criteria scores, respectively. 
However, as expected, no significant differences were found 
for initial rating-group assignment on either the Pretest 
Total score (E[l, 63] = 0.00, 2 > .95) or the Pretest 
Criteria score (E[l, 63] = 0.19, 2 > .66). Neither was 
there an interaction effect evident between case 
presentation and rating on either the Pretest Total scores 
(E[l,63] = 0.11, 2 > .74) or the Pretest Criteria scores 
(E[l,63] = 0.43, 2 > .51). Means and standard deviations 
for case-presentation groups and adjusted for Screening 
Criteria differences are listed in Table 4. 
Table 4 
Case-Presentation-Group Scores on Pretest Inventories 
No 
Case-Presentation 
Group 
case 
M 
SD 
Negative case 
M 
SD 
Pretest Inventory 
n Total Criteria 
35 
3.92 4 . 26 
0.33 0.43 
33 
4.07 4.45 
0.35 0.47 
Note. Higher scores indicate higher symptomatology. 
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The second two-by-two ANCOVA involved case presentation 
(i.e., no case versus negative case) and completion (i.e., 
posttest dropout versus full study) using Pretest Total and 
Pretest Criteria scores. A significant main effect was 
again noted for the case-presentation condition on the 
Pretest Total score (K[l, 63] = 7.08, p ~ .010) and the 
Pretest Criteria score (K[l, 63] = 8.34, p ~ .005). Effect 
sizes of 0.48 and 0.45 for case presentation were found for 
Pretest Total and Pretest Criteria scores, respectively. 
A second main effect was noted for the completion 
factor with both the Pretest Total (K[l, 63] = 6.76, p > 
.012) and the Pretest Criteria scores (K[l, 63] = 3.76, p > 
.057). Effect sizes of 1.92 and 1.98 were associated with 
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the Pretest Total and Pretest Criteria scores, respectively. 
Means and standard deviations for case-by-completion 
adjusted for Screening Criteria differences are listed in 
Table 5. (Also see Figure 2.) It was evident that no 
interaction effect existed between case presentation and 
completion for either Pretest Total scores (E[l,63] = 1.89, 
p > .17) or Pretest Criteria scores (E[l,63] = 0.79, p > 
• 3 7) • 
Posttest Analyses and 
Within-Subi?cts Design 
A multivariate-analysis-of-variance (MANOVA) approach 
to conducting a repeated-measures analysis compared pretest-
and posttest-retrospective ratings associated with case-
presentation (coded no-case and negative-case) and rating 
assignments (coded retrospective-only and retrospective-
plus-prospective). A significant main effect for time was 
found. Specifically, a decrease in symptom severity was 
noted across time for both Pre/Posttest (i.e., 
Retrospective) Total scores (E[l, 44] = 15.52, p ~ .00) and 
Pre/Posttest (i.e., Retrospective) Criteria scores (E[l,44] 
= 18.49, p ~ .00). Effect sizes of 0.56 and 0.63 were found 
for Retrospective Total and Retrospective Criteria scores, 
respectively. Means and standard deviations adjusted for 
Screening Criteria scores are listed in Table 6. (Also see 
Figure 3.) 
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Table 5 
Case-by-Completion Scores on Pretest Inventories 
Pretest Inventory 
Case-by-Completion n Total Criteria 
No case 
Posttest dropout 11 
M 3.57 3.81 
QQ 0.25 0.33 
Full study 24 
M 4.04 4.44 
SD 0.21 0.28 
Negative case 
Post test dropout 9 
M 3.70 3.96 
SD 0.27 0.36 
Full study 24 
M 4.18 4.62 
SD 0.28 0.37 
Note. Higher scores indicate higher symptomatology. 
No other significant contrasts were found either 
between or within groups in regard to Pre/Posttest Total 
scores (i.e., case-by-time (E{l, 44} = 0.10, p ~ .75], 
rating-by-time (E{l, 44} = 1.22, p > .27], and case-by-
rating-by-time (E{l, 44} 0.03, p > .87]). Neither were 
there significant differences found regarding Pre-/Posttest 
Criteria scores (i.e., case-by-time [E{l,44} = 0.17, p > 
Figure 2. 
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Table 6 
Scores Across Time on Pre/Posttest Inventories 
Pre/Posttest Inventory 
Time Period n Total Criteria 
Pretest 48 
M 3.97 4 . 37 
SD 0.49 0.63 
Post test 48 
M 3.62 3.89 
SD 0.75 0.88 
Note. Higher scores indicate higher symptomatology . 
. 68], rating-by-time [E{l,44} = 0.69, R > .41], and case-by-
rating-by-time [E{l,44} = 0.17, R > .68]). 
One other important point regarding prospective ratings 
is that they confirmed retrospective reports for only 6 of 
24 subjects (i.e., 25%) who completed that aspect of the 
study. 
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Figure 3. Time effects on retrospective symptoms. 
Note: Means are adjusted for Screening Criteria scores. 
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Hypotheses and Findings 
CHAPTER V 
DISCUSSION 
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Hypotheses of the present study fell under three main 
categories. First of all, it was hypothesized that the 
negative-case presentation of late-luteal-phase-dysphoric-
disorder (LLPDD) symptoms would model negative social 
stereotypes about the disorder among subjects. Thus, it was 
suspected that initial retrospective-symptom ratings for the 
two negative-case-presentation groups (i.e., groups 3 and 4) 
(see Figure 1) would reflect both more numerous and severe 
symptoms compared to the retrospective ratings of the no -
case-presentation groups (i.e., groups 1 and 2). 
Indeed, higher severity ratings were noted for those 
subjects who saw the case presentation compared to those who 
did not. It seems possible that the case presentation truly 
did impress subjects with a more negative, stereotypical 
view of their symptoms, thus elevating their initial 
retrospective scores. However, the impact of the case-
presentation condition was no longer evident by the time 
subjects completed posttest inventories. 
A behavioral-learning approach to explaining the impact 
of the negative-case presentation could also be considered. 
Perhaps subjects were merely patterning their responses to 
the inventory after those responses that had been modelled 
by the "subject" in the video clip. 
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Second, an interaction effect was expected between 
case-presentation condition and type of ratings. Relative 
to all other groups, subjects in the negative-case-
presentation, retrospective-only-rating condition (NegC/R) 
were expected to continue to report more severe symptoms 
over time. Subjects in the negative-case-presentation, 
retrospective-plus-prospective-rating condition (NegC/R+P), 
however, were expected to show the greatest within-group 
shift in symptom ratings over time, relative to all other 
groups, due to experiencing the prospective-rating process. 
The shift would reflect fewer and less severe symptoms. 
That interaction was not found . 
As was mentioned previously, to date, only one study 
has systematically examined the effects of daily self-
monitoring of premenstrual syndrome (PMS} on subjects' 
overall experience and view of their premenstrual 
symptomatology (Endicott & Halbreich, 1982). One of the 
intentions of this research was to duplicate the results of 
that study, with the exception that the more rigorously 
defined criteria for LLPDD would be substituted for the more 
loosely conceptualized criteria of PMS. That might impact 
efforts of the health profession also to develop more 
studies in line with LLPDD criteria versus those of PMS. 
In the present study, rating assignment per se, 
however, did not seem to impact subjects' final 
retrospective scores. Endicott and Halbreich had indicated 
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in their 1982 article that studies utilizing nonclinical 
populations such as college students were not likely to 
duplicate their results, which were based more specifically 
on a treatment-seeking population of women suffering 
extreme-intensity PMS. 
Also, no significant within-group changes over time 
were predicted for (a) subjects exposed to the no-case-
presentation, retrospective-only-rating condition (NoC/R) 
and (b) subjects exposed to the negative-case-presentation, 
retrospective-only-rating cond i tion (NegC/R) . That was 
anticipated because those subjects would have experienced no 
prospective-rating training, which would correct subjects' 
a priori response biases. Again, such was not the case. 
It would appear that the passage of time had a far 
greater influence on pre-to-posttest-severity ratings than 
did either case-presentation or rating-group assignment. 
What would account for such a decrease in severity of 
ratings for the entire sample across time? Kazdin (1980) 
referred to such "spontaneous remission" as being those 
"changes made without receiving formal treatment in a given 
investigation" (p. 143). He also referred to "multiple 
influences that may impinge on clients," whether or not they 
have been assigned to a formal treatment condition (p. 143). 
A possible explanation for the decrease in symptom 
severity over time in the present study could be that 
pretest inventories were administered at the beginnings of 
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academic quarters and the posttest inventories at the 
quarters' ends for all subjects. Perhaps the stress present 
at the beginnings of academic quarters somehow accentuates 
subjects' perceptions and recall of their symptomatology. 
Perhaps that stress level was universally reduced at the 
ends of academic quarters so that posttests of all women 
reflected that change in stress. 
The above assumption seems to cast considerable doubt 
on the validity of one-time retrospective reports of 
premenstrual symptomatology. Do retrospec t ively 
administered inventories truly measure what they purport to 
measure, or do confounding factors such as immediate 
subjective experience (e.g . , stereotypical views, stressors 
present at the time of administration) serve to distort 
memory? 
Another possible explanation for the apparent reduction 
in symptomatology among subjects is the multiple exposures 
to the testing materials through screening and initial 
retrospective assessments. In completing the first 
retrospective symptoms ratings, subjects could have been 
made more aware of their symptoms. They might, therefore, 
have begun attending to those symptoms during the 2-month 
time interval between pre- and post-retrospective 
assessments. Such self-monitoring on the part of subjects 
may have produced an effect similar to that induced by 
prospective ratings on symptom experience and report. 
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One final hypothesis emerged during the course of the 
study when it became clear that dropout rates for the 
retrospective-plus-prospective-rating groups were fairly 
high. It was presumed that there might exist some 
difference between dropouts and completers that could be 
detected in the pretest scores. It was the suspicion of the 
experimenter that pretest scores for full-study completers 
would be less severe, indicating an initially higher degree 
of physical and emotional health and, therefore , a 
heightened abil i ty to complete the prospective inventories . 
However, those subjects who subsequently completed the 
study tended to report higher severity on their ratings than 
did those subjects who failed to complete the study. It 
could have been that subjects who truly did experience 
higher symptomatology might have had a more vested interest 
in completing the study, thus accounting for higher pretest 
scores among those subjects meeting full-study completion. 
Limitations of the Present study 
and Research Recommendations 
A main limitation of the present study was the use of a 
population of college undergraduates attending a Utah 
university. It is an empirical question as to whether the 
results from using such a group would generalize to other 
populations (e.g., older populations, those with a greater 
percentage of women who had been married and had had 
children, non-LDS women, and those from various racial 
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backgrounds, as well as treatment-seeking, clinical 
populations). In light of the aforementioned limitation of 
the present study, it is suggested that other populations of 
women be studied for the purpose of determining 
generalizability of this study's results. 
Another possible limitation of this study is the fact 
that only self-defined symptomatic subjects were inducted 
into the study. That may have greatly limited the amount of 
change in severity of ratings for those subjects who were 
exposed to the negat i ve-case presentation of LLPDD symptoms . 
It i s suggested that self-defined asymptomatic subjects be 
admitted into future studies examining the effects of such a 
case-presentation so as to ascertain the full impact of 
induced negative stereotypes on subjects' ratings of their 
symptoms. 
Another limitation of the study is that pre- and 
postmenstrual ratings were collected for as short a time as 
one menstrual cycle for some of the subjects. That was also 
a limitation of the 1982 study by Endicott and Halbreich, 
which the present study hoped to correct. However, that 
proved to be an unrealistic goal considering the 8-week, 
prospective-rating interval during each academic quarter. 
Therefore, a possible way to improve upon both studies would 
be to gather ratings from at least two complete cycles as is 
suggested in DSM-III-R (APA, 1987). 
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Implications 
Results of the research at hand hold implications for 
both the medical profession as well as the target population 
of young adult females. Establishing a method for the 
accurate assessment of LLPDD would further the work of the 
clinician in both diagnostic and treatment efforts. Those 
clients truly suffering from the disorder should, therefore, 
have a greater opportunity for accurate diagnosis and 
successful treatment. 
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Appendix A 
IRB statement and Consent Form 
Statement of the Pl to the IRB for Proposed 
Research Involving Human Subjects 
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Proposal Title Do Prospective Ratings Correct Distortions Associated with 
Negative-Case Stereotypes of Premenstrual Syndrome (PMS) or Late Luteal 
Phase Dysphoric Disorder (LLPDD) Combined with Retrospective Ratings? 
Principal Investigator Dr. David Stein, Ph.D. 
Dept . PSY 
UMC 2810 
Ext. 3274 
Student Researcher Mary Stone 
Dept. PSY 
UMC 2810 
Ext. 1460 
This study will examine whether prospective ratings seem to correct 
distortions associated with negative-case stereotypes of premenstrual 
syndrome (PMS) or late luteal phase dysphoric disorder (LLPDD) combined 
with retrospective ratings. 
A. Human subjects who participate in this research will be asked to do the 
following: Initial screening of subjects will involve completion of a newly -
developed, self -report inventory, the Daily Assessment Form (DAF) (see 
attachment), presented simply as a list of "physical and emotional 
symptoms" "experienced by women within the past two months." 
Subjects who meet screening-inventory criteria will then be randomly 
assigned to one of four groups. All groups will be required to complete the 
OAF as it relates to their two most recent premenstrual or late-luteal phases. 
A two-month interval will then lapse before subjects are again required to 
complete the inventory retrospectively. Equal numbers of subjects from the 
retrospective-only-rating and retrospective-plus-prospective-rating groups will 
be assigned to either a no-case-presentation group or a negative-case 
presentation group. 
The negative-case-presentation groups will be exposed to a video clip 
presenting a "negative" (severe/chronic) definition of LLPDD just prior to 
taking the first retrospective DAF. Specifically, a "subject" (a confederate of 
the interviewer} will be retrospectively assessed for LLPDD using the DAF. 
The "subject" will respond to all LLPDD-relevant symptoms at a moderate-to-
extreme-severity level. In addition, she will avow all symptoms irrelevant to 
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LLPDD at a mild level of severity. Thus, the "negative" (chronic/severe) 
definition will showcase a rather poorly functioning, severe example of LLPDD, 
leading subjects to infer that it is "typical" of most patients. Subjects in the no-
case-presentation condition will simply complete their symptom ratings. 
Subjects in the retrospective-plus-prospective-rating conditions will complete 
both retrospective administrations of the OAF as well as two-months' 
prospective ratings. 
B. The Potential Benefits to be gained from the proposed research are: Results 
of the proposed research hold implications for both the medical profession as 
well as the target population of young adult females . Establishing a method for 
the accurate assessment of late luteal phase dysphoric disorder (LLPDD) would 
further the work of the clinician in both diagnostic and treatment efforts. Those 
clients truly suffering from the disorder should, therefore, have a greater 
opportunity for accurate diagnosis and successful treatment. 
As of yet , only one study has systematically examined the effects of daily self-
monitoring of PMS on subjects' overall experience and view of their 
premenstrual symptomatology. One of the intentions of the proposed research 
is to duplicate the results of that study, with the exception that the more-
rigorous criteria for LLPDD will be substituted for the more-loosely-defined 
criteria of premenstrual syndrome (PMS), furthering the efforts of the clinical 
profession to develop more studies in line with LLPDD criteria versus those of 
PMS. 
Another intention of the proposed research is to establish the validity of the 
hypothesis that faulty recall, based on negative expectations or stereotypical 
beliefs, underlies discrepancies found between retrospective and prospective 
assessments of PMS or LLPDD. Experimental induction of such expectations 
or beliefs via presentation of a negative-case example will be employed for that 
purpose. 
C. The risk(s) to the rights and welfare of human subjects involved are: No or 
minimal risk(s) to subjects is/are foreseen. The primary potential risk is loss of 
confidentiality. All data gathered on subjects will have identifying information 
removed, and will be placed in a database containing number-coded, group 
data. The potential compromises to confidentiality are minimal, and are thus, 
attended to by the researchers. 
D. In addition, the following safeguards/measures to mitigate/minimize the 
identified risks will be taken: NA 
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E. The informed consent procedures for subjects will be as follows: (Explain 
procedures to be followed, and attach an example of the informed consent 
instrument.) A copy of the consent form (see attachment), affixed to each 
DAF, will be distributed to female subjects recruited from several large 
undergraduate classes convening on Utah State University campus. Subjects 
will be asked to review the form and then to sign and date it at will, handing it 
in to their instructors separately from the inventory. Subjects will be asked not 
to put any identifying information on the inventory. A special I.D. code will be 
printed on both the consent form and the inventory so as to identify a given set 
of responses without jeopardizing confidentiality. Subjects will complete the 
DAF in the privacy of their homes, and return it to class the following day. 
F. The following measures regarding confidentiality of subjects will be t aken: 
As noted previously, a special I.D. code will be assigned to each subject so that 
only the principal investigator and the research assistants will be able to match 
up responses on the inventory to a given subject . 
~?ti}) 
Dr. David Stein, Ph.D 
Principal Investigator 
Mary St6ne 'r 
Student Researcher 
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Consent Form 
If you are FEMALE, are BETWEEN the ages of 18 AND 45, have NOT undergone 
SURGERY for the removal of both ovaries, are NOT currently taking any form of 
ORAL CONTRACEPTIVE, are NOT PREGNANT and HAVE EXPERIENCED 
MENSTRUATION (HAVE HAD A PERIOD) DURING THE PAST 2 MONTHS, PLEASE 
CONTINUE. OTHERWISE, PLEASE HAND THE PACKED BACK IN. THANK YOU! 
The purpose of this study is to examine how well a newly-developed, self-report 
inventory, the Daily Assessment Form (OAF), relates to some important physical 
and emotional symptoms that affect many women. This inventory should aid the 
efforts of both clinicians and researchers in determining symptom presence. 
In this study, you are asked to volunteer approximately 5 minutes of your class 
time to complete the OAF. IF YOU CHOOSE NOT TO DO SO, PLEASE HAND THE 
PACKET BACK IN . THANK YOU! 
FOR THOSE WHO DO CHOOSE TO COMPLETE THE DAF, PLEASE FILL THIS 
CONSENT FORM. THEN USE THE ATTACHED COMPUTER SHEET IN 
COMPLETING BOTH SIDES OF THE INVENTORY. FILL IN THE CIRCLE 
CORRESPONDING TO THE MAXIMUM DEGREE OF SEVERITY FOR EACH 
SYMPTOM YOU EXPERIENCED WITHIN THE PAST 2 MONTHS. THE 
SYMPTOM(S) NEED NOT HAVE PERSISTED THROUGHOUT THE ENTIRE 2-
MONTH INTERVAL, BUT MUST HAVE BEEN PRESENT AT SOME POINT DURING 
THE RATING PERIOD TO RECEIVE A SCORE GREATER THAN 0. PLEASE HAND 
THE COMPLETED PACKET BACK IN WHEN YOU ARE FINISHED. THANK YOU! 
All of the answers that you give will be held in complete conf idence . This 
means that no one but the principal investigator (Dr . David Stein, Ph.D.) and his 
research assistants will have access to this information. A special I.D. code will 
be assigned to each participant for the sake of maintaining confidentiality . 
PLEASE DO NOT PUT ANY IDENTIFYING INFORMATION ON THE COMPUTER 
SHEET, OR MARK THE INVENTORY IN ANY WAY! 
Completing the DAF may make you eligible for further study participation , for 
which an incentive may be provided. However , you may withdraw your consent 
to participate at any time, and will suffer no penalty for doing so . 
Any questions regarding this research may be directed to Dr. David Stein (USU 
PSY Dept ., 750 -3274). 
NAME 
AGE 
PHONE# 
SIGNATURE 
TODAY'S DATE 
72 
Appendix B 
Permission Notification and Daily Assessment Form 
University of Pittsburgh 
WESTERN PSYCHIATRIC INSTITUTE AND CLINIC 
Mary Stone 
69 1/2 N. 200 W. #4 
Logan, Utah 84321 
Dear Ms. Stone: 
Thank you for your interest in our Daily Assessment Form (DAF) 
which you hope to use for a study of retrospective versus 
prospective assessment approaches in diagnosing LLPDD. Dr. Frank 
and I have no objection to your using the instrument in your thesis 
research provided you furnish us with a copy of your study results. 
I wish you success in your research endeavor. 
Very truly yours, 
<.J /) . #---; . 
l/_/L:',_, :,,;\,c.f--:° ,~,<~· _jc-1'!i_;;_,, /\.cL 
Ana Rivera-Tova~, Ph.D. 
3811 O'HARA STREET, PITTSBURGH. PA 15213-2593 
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Daily Assessment Form 
(Pearlstein T, Rivera-Tovar A & Frank E, 1986) 
Please use the attached computer sheet in completing both sides of this 
inventory. Fill in the circle corresponding to the maximum degree of severity for 
each symptom you experienced within the past 2 months. 
0-None (feature not present at all) 
1 -Minimal (only slightly apparent to you, others would probably not be aware of 
it) 
2-Mild (definitely apparent to you and perhaps to others who know you well) 
3-Moderate (clearly apparent to you and/or others who know you well) 
4-Severe (very apparent to you and/or others who know you well) 
5-Extreme (the degree of severity is so extreme that it is very apparent to you 
OR even people who do not know you well might notice) 
1) Irritable, angry, impatient O 2 3 4 5 
2) Low energy, fatigue, 
feel unable to move O 2 3 4 5 
3) Feel overwhelmed O 2 3 4 5 
4) Mood swings, feel labile, 
emotions feel out of control O 2 3 4 5 
5) Anxious, jittery, nervous O 2 3 4 5 
6) Feel excited, bursts of energy O 2 3 4 5 
7) Headaches O 2 3 4 5 
8) Breast tenderness or swelling O 2 3 4 5 
9) Forgetful, confused O 2 3 4 5 
10) Depressed, sad, low, blue, tearful O 2 3 4 5 
11) Decreased self-esteem, insecure O 2 3 4 5 
12) Decreased appetite, eat less O 2 3 4 5 
13) React intensely to "+" 
or "-" daily events O 2 3 4 5 
14) Feel more efficient, 
increased orderliness O 2 3 4 5 
1 5) Abdominal pain O 2 3 4 5 
1 6) Distractable, difficulty 
concentrating O 2 3 4 5 
17) Pessimistic, gloomy, despondent O 2 3 4 5 
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1 8) Guilt feelings, brood over events 0 2 3 4 5 
19) Decreased sleep 0 2 3 4 5 
20) Active, restless, "can't sit still 0 2 3 4 5 
21) Increased appetite, eat more 0 2 3 4 5 
22) Abdominal bloating or swelling 0 2 3 4 5 
23) Desire to be alone 0 2 3 4 5 
24) Sensitive to criticism or rejection 
from others, easily hurt 0 2 3 4 5 
25) More affectionate feelings , 
more sexual interest 0 2 3 4 5 
26) Back, joint, or muscle pain 0 2 3 4 5 
27) Poor performance, 
impaired functioning 
at home, work or school 0 2 3 4 5 
28) Loss of interest or pleasure 
in usual activities 0 2 3 4 5 
29) Increased sleep , naps, stay in bed 0 2 3 4 5 
30) Sense of well-being, 
more enjoyment of things 0 2 3 4 5 
31) Avoid social commitments 0 2 3 4 5 
32) Lowered motor coordination, 
feel clumsy, minor accidents 0 2 3 4 5 
33) Less sexual interest 0 2 3 4 5 
